Mif participates in Toxoplasma gondii-induced pathology following oral infection

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Cavalcanti, Marta G ^a   Mesquita, Jacilene S ^a   Madi, Kalil ^a,b   Feijó, Daniel F ^a   Miranda Assunção, Iranaia ^a   Souza, Heitor S P ^a   Bozza, Marcelo T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Laboratorio Sergio Franco   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 12; INTERLEUKIN 22; INTERLEUKIN 23; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTERITIS; FEMALE; ILEUM MUCOSA; INTESTINE PARASITE; LETHALITY; LIVER INJURY; MALE; MORBIDITY; MORTALITY; MOUSE; MOUTH INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE LOAD; PATHOGENESIS; TISSUE INJURY; TOXOPLASMA GONDII; WILD TYPE; ANIMAL; C57BL MOUSE; ENZYMOLOGY; ILEITIS; ILEUM; INTESTINE MUCOSA; METABOLISM; MOUTH; PARASITOLOGY; PATHOLOGY; PHYSIOLOGY; SEPSIS; SURVIVAL; TOXOPLASMA; TOXOPLASMOSIS;

MUS; TOXOPLASMA GONDII;

ANIMALS; CYTOKINES; ILEITIS; ILEUM; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MOUTH; PARASITE LOAD; SEPSIS; SURVIVAL ANALYSIS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 80053087407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025259     Document Type: Article

References (54)

1. Liesenfeld O, (2002) Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? J Infect Dis 185: S96-101.
2. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, et al. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α. J Immunol 157: 798-805.
3. Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH, (2006) Mucosal defenses against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell Microbiol 8: 535-544.
4. Denkers EY, Gazzinelli RT, (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11: 569-588.
5. Yap GS, Sher A, (1999) Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J Exp Med 189: 1083-1092.
6. Tait ED, Hunter CA, (2009) Advances in understanding immunity to Toxoplasma gondii. Mem Inst Oswaldo Cruz 104: 201-210.
7. Muñoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, et al. (2009) Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J Exp Med 206: 3047-3059.
8. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD, (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167: 4574-4584.
9. Mennechet FJD, Kasper LH, Rachinel N, Li W, Vandewalle A, et al. (2002) Lamina propria CD4+T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory responses against intracellular pathogen. J Immunol 168: 2988-2996.
10. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759.
11. Bucala R, (1996) MIF rediscovered cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10: 1607-1613.
12. Calandra TJ, Roger T, (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nature Rev Immunol 3: 791-800.
13. Weber C, Kraemer S, Drechsler M, Lue H, Koenen RR, et al. (2008) Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc Natl Acad Sci U S A 105: 16278-16283.
14. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, et al. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68-71.
15. Calandra T, Bernhagen J, Mitchell RA, Bucala R, (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902.
16. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J, (2002) Macrophage migration inhibitory factor (MIF): mechanism of action and role in disease. Microbes Infect 4: 449-460.
17. Roger T, David J, Glauser MP, Calandra T, (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 4414: 920-924.
18. Dunne DW, Shaw A, Bockenstedt LK, Allore HG, Chen S, (2010) Increased TLR4 expression and downstream cytokine production in immunosuppressed adults compared to non-immunosuppressed adults. PLoS One 5: e11343.
19. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, et al. (1999) Target disruption of Migration Inhibitory Factor gene reveals its critical role in sepsis. J Exp Med 189: 341-346.
20. De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, et al. (2001) Development of chronic colitis is dependent on the cytokine MIF. Nature Immunol 2: 1061-066.
21. Satoskar AR, Bozza M, Rodriguez-Sosa M, Lin G, David JR, (2001) Migration-Inhibitory gene deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 69: 1247-1254.
22. Magalhães ES, Mourao-Sa DS, Vieira-de-Abreu A, Figueiredo RT, Pires AL, et al. (2007) Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. Eur J Immunol 37: 1097-1106.
23. Paiva CN, Arras RH, Magalhães ES, Alves LS, Lessa LP, et al. (2009) Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction. J Leukoc Biol 85: 855-861.
24. McDevitt MA, Xie J, Shanmugasundaram G, Griffith J, Liu A, et al. (2006) Critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 193: 1-12.
25. Magalhães ES, Paiva CN, Souza HS, Pyrrho AS, Mourão-Sá D, et al. (2009) Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. FASEB J 23: 1262-1271.
26. Reyes JL, Terrazas LI, Espinoza B, Cruz-Robles D, Soto V, et al. (2006) Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect Immun 72: 3571-3576.
27. Flores M, Saavedra R, Bautista R, Viedma R, Tenorio EP, et al. (2008) Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J 22: 3661-3671.
28. Terrazas CA, Juarez I, Terrazas LI, Saavedra R, Calleja EA, et al. (2010) Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF deficient mice favors susceptibility to infection. Exp Parasitol 126: 348-358.
29. Liesenfeld O, Kosek J, Remington JS, Suzuki Y, (1996) Association of CD4+ Tcell-dependent interferon γ mediated necrosis of the small intestine with genetic susceptibility of mice to per oral infection with Toxoplasma gondii. J Exp Med 184: 597-607.
30. Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe C, et al. (1999) TNF-α, nitric oxide and IFN-γ are all critical for development of necrosis in small intestine and early mortality in genetically susceptible mice infected per orally with Toxoplasma gondii. Parasite Immun 21: 365-376.
31. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following per oral infection with Toxoplasma gondii. J Immunol 164: 5375-5382.
32. Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM, (2003) Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis 3: 7.
33. Kompalic-Cristo A, Frotta C, Suárez-Mutis M, Fernandes O, Britto C, (2007) Evaluation of a real-time PCR assay based on the repetitive B1 gene for the detection of Toxoplasma gondii in human peripheral blood. Parasitol Res 101: 619-625.
34. Heimesaat MM, Bereswill S, Fischer A, Niebergall J, Freudenberg M, et al. (2006) Gram-negative bacteria aggravate murine small intestinal Th-1 type immunopathology following oral infection with Toxoplasma gondii. J Immunol 177: 8785-8795.
35. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)). Method Methods 25: 402-408.
36. Roberts CW, Ferguson DJ, Jebbari H, Satoskar A, Bluethmann H, Alexander J, (1996) Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect Immun 64: 897-904.
37. Nickdel MB, Lyons RE, Roberts F, Brombacher F, Hunter CA, et al. (2004) Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol 26: 75-82.
38. Neves ES, Bicudo LN, Curi AL, Carregal E, Bueno WF, et al. (2009) Acute acquired toxoplasmosis: clinical-laboratorial aspects and ophthalmologic evaluation in a cohort of immunocompetent patients. Mem Inst Oswaldo Cruz 104 (2): 393-6.
39. Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, et al. (2006) Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis. Arthritis Res Ther 8: 1-14.
40. Assunção-Miranda I, Bozza MT, Da Poian AT, (2010) Pro-inflammatory response resulting from sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis. J Med Virol 82: 164-174.
41. Munoz M, Liesenfeld O, Heimesaat MM, (2011) Immunology of Toxoplasma gondii. Immunol Rev 240: 269-285.
42. Ohkawara T, Nishihira J, Ishiguro Y, (2006) Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice. Immunol Lett 107: 148-154.
43. Aujla SJ, Kolls JK, (2009) IL-22: a critical mediator in mucosal host defense. J Mol Med 87: 451-454.
44. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, et al. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40: 2450-2459.
45. Brembilla NC, Ramirez JM, Chicheportiche R, Sorg O, Saurat JH, et al. (2011) In vivo dioxin favors interleukin-22 production by human CD4+ T cells in an aryl hydrocarbon receptor (AhR)-dependent manner. PLoS One 6: e18741.
46. Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, et al. (2011) Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract. Gastroenterology 141: 237-248.
47. Garg P, Vijay-Kumar M, Wang L, Gewirtz AT, Merlin D, et al. (2009) Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. Am J Physiol Gastrointest Liver Physiol 296: G175-184.
48. Chou YT, Wang H, Chen Y, Danielpour D, Yang YC, (2006) Cited2 modulates TGF-beta-mediated upregulation of MMP9. Oncogene 25: 5547-5560.
49. He XX, Chen K, Yang J, Li XY, Gan HY, (2009) Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 15: 1-10.
50. Assunção-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, et al. (2010) Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J 24: 218-228.
51. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, et al. (2007) Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948.
52. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. (2005) TLR-11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629.
53. Ferro EA, Mineo JR, Ietta F, Bechi N, Romagnoli R, et al. (2008) Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants. Am J Pathol 172: 50-58.
54. de Oliveira Gomes A, de Oliveira Silva DA, Silva NM, de Freitas Barbosa B, Franco PS, et al. (2011) Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age. Am J Pathol 178: 2792-2801.